Dr Michael T Mattingly, MD | |
309 New St, Greensboro, NC 27405-3654 | |
(336) 379-9708 | |
(336) 379-8714 |
Full Name | Dr Michael T Mattingly |
---|---|
Gender | Male |
Speciality | Internal Medicine - Nephrology |
Location | 309 New St, Greensboro, North Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477592673 | NPI | - | NPPES |
390004560 | Other | NC | RRM PROVIDER # |
19495 | Other | NC | PARTNERS |
1036N | Other | NC | BCBS PROVIDER # |
561274347 | Other | NC | CKA'S TAX ID # |
891036N | Medicaid | NC | |
3102727 | Other | NC | UHC PROVIDER # |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | 9500996 (North Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Michael T Mattingly, MD 309 New St, Greensboro, NC 27405-3654 Ph: (336) 379-9708 | Dr Michael T Mattingly, MD 309 New St, Greensboro, NC 27405-3654 Ph: (336) 379-9708 |
News Archive
Quotient Clinical, the Translational Pharmaceutics Company, has announced a significant expansion of its pharmaceutical sciences capabilities, doubling capacity through the acquisition of a second GMP manufacturing facility and the construction of new formulation development and pharmaceutical analysis laboratories.
Amgen and Merck, known as MSD outside the U.S. and Canada, today announced an expanded collaboration to evaluate the efficacy and safety of talimogene laherparepvec, Amgen's investigational oncolytic immunotherapy, in combination with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in a Phase 1, open-label trial of patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN).
Aging-US published "The role of age at menarche and age at menopause in Alzheimer's disease: evidence from a bidirectional mendelian randomization study" which reported that the association between endogenous estrogen exposure and Alzheimer's disease remains inconclusive in previous observational studies, and few Mendelian randomization studies have focused on their causality thus far.
A pair of oncologists in the Program in Women's Oncology at Women & Infants Hospital of Rhode Island recently co-authored a pocket-sized guide to the human papilloma virus (HPV) so physicians can make more accurate diagnosis and plan more effective treatment for women with the virus.
Lutheran Medical Center (LMC) and Medsphere Systems Corporation today announced the successful implementation of Medsphere's OpenVista® electronic health record (EHR) solution throughout the hospital. The full service 476-bed teaching hospital is now on track to achieve meaningful use and qualify for millions of dollars made available by the American Recovery and Reinvestment Act of 2009.
› Verified 6 days ago
Dr. Olugbemiga Ebenezer Jegede, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 201 E Wendover Ave, Greensboro, NC 27401 Phone: 336-832-4444 Fax: 336-832-4445 | |
Yan Feng, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 501 N Elam Ave, Greensboro, NC 27403 Phone: 336-832-1100 | |
Dr. Gary Bradley Sherrill, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 501 N Elam Ave, Greensboro, NC 27403 Phone: 336-832-1100 | |
Edwin Aziegbe Avbuere, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3231 Yanceyville Street, Greensboro, NC 27405 Phone: 336-358-1528 Fax: 336-358-1582 | |
Dr. Jay Krishnavadan Patel, MB.CHB Nephrology Medicare: Accepting Medicare Assignments Practice Location: 309 New St, Carolina Kidney Associates, Greensboro, NC 27405 Phone: 336-379-9708 Fax: 336-553-2085 | |
Gayatri A Acharya, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3200 Northline Ave Ste 250, Greensboro, NC 27408 Phone: 336-273-7900 | |
Murali Ramaswamy, MD FAAFP Nephrology Medicare: Accepting Medicare Assignments Practice Location: 520 N Elam Ave, Greensboro, NC 27403 Phone: 336-547-1801 Fax: 336-547-1828 |